Campbell & CO Investment Adviser LLC Amphastar Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$38.65 - $43.48 $198,042 - $222,791	-5,124 Reduced 37.15%	8,668 $346,000
Q1 2024 May 10, 2024	BUY	$42.85 - $63.45 $590,987 - $875,102	13,792 New	13,792 $605,000
Q1 2022 May 09, 2022	SELL	$22.96 - $36.45 $339,808 - $539,460	-14,800 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$18.14 - $23.29 $76,188 - $97,818	4,200 Added 39.62%	14,800 $345,000
Q3 2021 Nov 10, 2021	BUY	$17.83 - $21.49 $188,997 - $227,793	10,600 New	10,600 $202,000
Q2 2021 Aug 11, 2021	SELL	$17.11 - $20.92 $204,652 - $250,224	-11,961 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $63,091 - $75,702	-3,666 Reduced 23.46%	11,961 $219,000
Q4 2020 Feb 09, 2021	SELL	$17.76 - $21.24 $8,880 - $10,620	-500 Reduced 3.1%	15,627 $314,000
Q3 2020 Oct 15, 2020	SELL	$17.99 - $22.22 $53,969 - $66,660	-3,000 Reduced 15.68%	16,127 $302,000
Q2 2020 Jul 29, 2020	BUY	$14.25 - $22.46 $272,559 - $429,592	19,127 New	19,127 $430,000
Q2 2018 Jul 13, 2018	SELL	$14.63 - $19.6 $341,478 - $457,483	-23,341 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$17.23 - $20.35 $402,165 - $474,989	23,341 New	23,341 $438,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.